Progyny, Inc. – NASDAQ:PGNY
Progyny stock price today
$22.35
+5.45
+32.25%
Financial Health
0
1
2
3
4
5
6
7
8
9
Market closed
Open in 2 days
Progyny stock price monthly change
-41.62%
month
Progyny stock price quarterly change
-41.62%
quarter
Progyny stock price yearly change
-55.24%
year
Progyny key metrics
Market Cap | 1.22B |
Enterprise value | 2.92B |
P/E | 108.83 |
EV/Sales | 3.71 |
EV/EBITDA | 108.94 |
Price/Sales | 3.86 |
Price/Book | 8.05 |
PEG ratio | -2.01 |
EPS | 0.65 |
Revenue | 1.10B |
EBITDA | 67.51M |
Income | 61.25M |
Revenue Q/Q | 7.61% |
Revenue Y/Y | 26.93% |
Profit margin | 3.86% |
Oper. margin | 2.97% |
Gross margin | 21.26% |
EBIT margin | 2.97% |
EBITDA margin | 6.09% |
Sign up &
create your own Smart Feed
create your own Smart Feed
Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.
Sign up for freeProgyny stock price history
Progyny stock forecast
Progyny financial statements
Average Price Target
$22.63
Potential upside: 1.23%
Analysts Price target
Financials & Ratios estimates
| Jun 2023 | 279.37M | 14.99M | 5.37% |
|---|---|---|---|
| Sep 2023 | 280.89M | 15.89M | 5.66% |
| Dec 2023 | 269.94M | 13.47M | 4.99% |
| Mar 2024 | 278.07M | 16.89M | 6.08% |
| Jun 2023 | 681537000 | 212.03M | 31.11% |
|---|---|---|---|
| Sep 2023 | 726512000 | 211.11M | 29.06% |
| Dec 2023 | 756620000 | 203.19M | 26.86% |
| Mar 2024 | 794304000 | 222.7M | 28.04% |
| Jun 2023 | 76.01M | -58.92M | -1.83M |
|---|---|---|---|
| Sep 2023 | 54.18M | -64.31M | -2.36M |
| Dec 2023 | 37.65M | -93.41M | -5.02M |
| Mar 2024 | 25.73M | 19.34M | -27.41M |
Progyny alternative data
| Aug 2023 | 393 |
|---|---|
| Sep 2023 | 393 |
| Oct 2023 | 393 |
| Nov 2023 | 393 |
| Dec 2023 | 393 |
| Jan 2024 | 393 |
| Feb 2024 | 393 |
| Mar 2024 | 563 |
| Apr 2024 | 563 |
| May 2024 | 563 |
| Jun 2024 | 563 |
| Jul 2024 | 563 |
Progyny other data
75.59%
-5.92%
of PGNY is owned by hedge funds
255
+17
75.34M
-6.11M
shares is hold by hedge funds
What is insider trading?
| Period | Buy | Sel |
|---|---|---|
| Jun 2024 | 0 | 1462 |
| Jul 2024 | 0 | 9030 |
| Dec 2024 | 359500 | 0 |
| Transaction | Date | Insider | Security | Shares | Price per share | Total value | Source |
|---|---|---|---|---|---|---|---|
Purchase | SCHLANGER DAVID J director, officer.. | Common Stock | 150,000 | $14.68 | $2,202,300 | ||
Purchase | ANEVSKI PETER director, officer.. | Common Stock | 209,500 | $14.48 | $3,034,189 | ||
Sale | STURMER MICHAEL E officer: PRESIDENT | Common Stock | 9,030 | $30 | $270,900 | ||
Sale | SCOTT CHERYL director | Common Stock | 1,462 | $28.39 | $41,506 | ||
Option | SCHLANGER DAVID J director, officer.. | Stock Option (Right to Buy) | 80,000 | $3.96 | $316,400 | ||
Option | SCHLANGER DAVID J director, officer.. | Common Stock | 80,000 | $3.96 | $316,400 | ||
Sale | SCHLANGER DAVID J director, officer.. | Common Stock | 80,000 | $38.11 | $3,048,400 | ||
Option | SCHLANGER DAVID J director, officer.. | Stock Option (Right to Buy) | 80,000 | $3.96 | $316,400 | ||
Sale | SCHLANGER DAVID J director, officer.. | Common Stock | 80,000 | $37.65 | $3,011,920 | ||
Option | SCHLANGER DAVID J director, officer.. | Stock Option (Right to Buy) | 2,906 | $3.96 | $11,493 |
| Patent |
|---|
Grant Filling date: 20 Mar 2015 Issue date: 9 Mar 2021 |
Grant Filling date: 20 Sep 2016 Issue date: 17 Dec 2019 |
| Quarter | Transcript |
|---|---|
| Q1 2024 9 May 2024 | Q1 2024 Earnings Call Transcript |
| Q4 2023 27 Feb 2024 | Q4 2023 Earnings Call Transcript |
| Q3 2023 7 Nov 2023 | Q3 2023 Earnings Call Transcript |
| Q2 2023 3 Aug 2023 | Q2 2023 Earnings Call Transcript |
Progyny: Recent Stock Decline Provides Buying Opportunity
June 2024 New Analysts Cover Uber, TG Therapeutics, CarMax, And More
Progyny: At This Price, Secular Tailwinds Are Too Compelling To Ignore
Centene Corporation: A Great Business At A Great Price
Progyny: No Change To Long-Term Outlook
Progyny Inc.: Resilient Business Model With Strong Growth Ahead
Progyny: 4 Reasons I Bought This Stock
Progyny: Strong Secular Tailwind, Great Performance, Recommend Long
Progyny: No Issues With Growing Healthily Ahead
-
What's the price of Progyny stock today?
One share of Progyny stock can currently be purchased for approximately $22.35.
-
When is Progyny's next earnings date?
Unfortunately, Progyny's (PGNY) next earnings date is currently unknown.
-
Does Progyny pay dividends?
No, Progyny does not pay dividends.
-
How much money does Progyny make?
Progyny has a market capitalization of 1.22B and it's past years’ income statements indicate that its last revenue has increased compared to the previous period by 38.34% to 1.09B US dollars.
-
What is Progyny's stock symbol?
Progyny, Inc. is traded on the NASDAQ under the ticker symbol "PGNY".
-
What is Progyny's primary industry?
Company operates in the Healthcare sector and Medical - Healthcare Information Services industry.
-
How do i buy shares of Progyny?
Shares of Progyny can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
-
Who are Progyny's key executives?
Progyny's management team includes the following people:
- Mr. David J. Schlanger Executive Chairman(age: 66, pay: $987,310)
- Mr. Peter Anevski Chief Executive Officer & Chief Operating Officer(age: 58, pay: $909,860)
- Mr. Mark S. Livingston Chief Financial Officer(age: 59, pay: $857,010)
- Ms. Jennifer Bealer Executive Vice President, Gen. Counsel & Sec.(age: 44, pay: $499,120)
-
How many employees does Progyny have?
As Jul 2024, Progyny employs 563 workers.
-
When Progyny went public?
Progyny, Inc. is publicly traded company for more then 5 years since IPO on 25 Oct 2019.
-
What is Progyny's official website?
The official website for Progyny is progyny.com.
-
Where are Progyny's headquarters?
Progyny is headquartered at 1359 Broadway, New York, NY.
-
How can i contact Progyny?
Progyny's mailing address is 1359 Broadway, New York, NY and company can be reached via phone at +212 8883124.
-
What is Progyny stock forecast & price target?
Based on 5 Wall Street analysts` predicted price targets for Progyny in the last 12 months, the avarage price target is $22.63. The average price target represents a 1.23% change from the last price of $22.35.
Progyny company profile:
Progyny, Inc.
progyny.comExchange:
NASDAQ
Full time employees:
563
Industry:
Medical - Healthcare Information Services
Sector:
Healthcare
Progyny, Inc., a benefits management company, specializes in fertility and family building benefits solutions for employers in the United States. Its fertility benefits solution includes differentiated benefits plan design, personalized concierge-style member support services, and selective network of fertility specialists. The company also offers Progyny Rx, an integrated pharmacy benefits solution that provides its members with access to the medications needed during their treatment. In addition, it provides surrogacy and adoption reimbursement programs for employers. The company was formerly known as Auxogyn, Inc. and changed its name to Progyny, Inc. in 2015. Progyny, Inc. was incorporated in 2008 and is headquartered in New York, New York.
1359 Broadway
New York, NY 10018
New York, NY 10018
CIK: 0001551306
ISIN: US74340E1038
CUSIP: 74340E103
